ORC, CDC6 and MCM proteins assemble sequentially to form prereplication chromatin.
INTRODUCTION
It has been suggested that nucleic acid metabolism is carried out on spatially organized domain structures in the cell nucleus (reviewed in Ref. 1) . Non-chromatin nuclear structures such as "the nuclear matrix", "the scaffold ", and "the nucleoskeleton" has been suggested as key players in organizing high-order chromatin/nuclear structures (reviewed in Refs.2 and 3).
In the case of DNA replication, for example, fluorescence microscopic analyses have revealed discrete granular sites of replication, i.e. replication sites or replication foci (4) (5) (6) (7) . Replication foci may be constructed based on non-chromatin nuclear structures, since nascent DNA and many proteins involved in DNA synthesis have been found to attach to these (8, 9 : also reviewed in Refs.2 and 3). In addition, non-chromatin nuclear elements have also been implicated in the initiation step of DNA replication (reviewed in Ref.10); replication origins are often situated close to matrix/scaffold-attachment regions (11) (12) (13) (14) . In this regard, it is of interest to ascertain how replication initiation proteins such as the origin recognition complex (ORC) 1 4 also required for the prereplication complex formation (18, 19) .
However, the mode of organization remains largely unknown, especially in higher eukaryots. For example, in the Xenopus egg extract system, it is unknown how ORC interacts with DNA, and so far physical interactions have not been detected among ORC, CDC6, and the MCM complex (20, 21) . In addition, in mammalian cells, it is also controversial whether a stable ORC hexamer is present. To understand regulation of DNA replication in mammalian cells, we have been analyzing the spatiotemporal organization of ORC, CDC6 and MCM proteins. We previously developed a method which enables us to remove about 70% of chromatin from HeLa cell nuclei by DNase I digestion under relatively physiological conditions. Using this method, it has been shown that human MCM heterohexamers are associated the removable chromatin while ORC1 and CDC6 proteins bind to nuclease-resistant structures (22-24). As described above, it would be intriguing if ORC1 and CDC6 were associated with nonchromatin nuclear structures. However, this has hitherto not been addressed adequately (for details see below aphidicolin treatment for 14-18 h, or in G2/M phase with 50ng
nocodazole treatment for 14-18 h. Cells in mid to late G1 phase were obtained, as described previously (23) . MG132 (Z-Leu-Leu-Leu-CHO) dissolved in DMSO at 20mM was added to cultures at a final concentration of 20µM. As a control, cells treated with 0.1% DMSO were also prepared.
In vivo cross-linking of viable cells with DSP
HeLa cells in 100mm plates were washed three times with phosphate-buffered saline (PBS) at room temperature, mixed with 10ml cross-link buffer (23) and DSP dissolved in DMSO was added to a final concentration of 200µg/ml. The plates were gently swirled for 10min at room temperature, and the reaction was quenched by adding 10ml of TE buffer (10mM Tris-HCl, pH7.6, 1mM EDTA). The cells were then further washed twice with ice-cold PBS.
Cell fractionation
DSP-treated cells were lysed for 5 min on ice with 1ml of ice-cold 0.1%TX-100mCSK buffer (22) without dithiothreitol and ATP.
Multiple protease inhibitors, 200µM Na3VO4 and 20mM NaF were also added to the buffer. The cells were then subjected to centrifugation to obtain Triton X-100-extractable fractions. The extracted nuclei 6 were further extracted with 0.5M NaCl/NP-40 buffer (0.5M NaCl, 1%
Nonidet P-40, 10mM Tris-HCl, pH 7.6) and centrifuged to obtain the salt-extractable fractions. The Triton-and salt-extracted nuclei were digested with 1000U/ml DNase I (10U/µl, Boehringer Mannheim) in 0.1%TX-100mCSK containing 2mM MgCl2 and the multiple protease inhibitors at 25 o C for 30min, and then NaCl was added to a final concentration of 0.5M. The samples were then centrifuged to obtain the solubilized chromatin fraction and the remaining non-chromatin nuclear structure. The samples were added to the same volumes of 2x SDS-sample buffer (26) and boiled.
Antibodies
A thioredoxin fusion protein containing amino acids 1 to 145 of human ORC2 was produced in E. coli according to the manufacturer's instruction (Invitrogen). Rabbits were injected with the purified fusion protein, and anti-ORC2 antibodies were affinity-purified from the antiserum, as described (23, 26 Preparation and specificity of the anti-human MCM7 and CDC6 rabbit polyclonal antibodies were described previously (23, 26) .
Anti-HA rat (3F10) or mouse (HA.11) monoclonal antibodies were 7 purchased from Roche and BAbCO, respectively, and an anti-PCNA mouse monoclonal antibody (PC10) from DAKO.
Immunoprecipitation and immunoblotting
For immunoprecipitation after in vivo DSP cross-linking, HeLa cells in 100mm plates were lysed on ice in 0.1%TX-100mCSK buffer. The soluble fraction was separated by centrifugation, and SDS was added to a final concentration of 0.15%. The nuclear pellet was resuspended into 100µl of RIPA buffer (26) containing 1.5% SDS, diluted with NET gel buffer (50mM Tris-HCl, pH7.5, 150mM NaCl, 0.1%
Triton X-100, 1mM EDTA), and sonicated. Separate aliquots of the lysates were immunoprecipitated with antibody-fixed beads.
For immunoprecipitation with anti-HA antibody, 0.1%TX-100mCSK-extracted nuclei isolated as described above were resuspended into 1ml of 250NTT buffer (250mM NaCl, 0.5% Triton X-100, 50mM Tris-HCl pH7.5), and the nuclear extracts were clarified by centrifugation. Separate aliquots of the extracts were then mixed with the anti-HA antibody 3F10 and further incubated after addition of protein G-agarose beads. The beads were washed with 250NTT
buffer.
Immunoblotting was performed as described previously (26) .
Antibody binding was visualized using the ECL system (Amersham).
Immunofluorescence analyses
All staining procedures were carried out at room temperature except for extraction and incubation with primary antibodies. The samples were mounted in Vectashield (Vector Laboratories).
Image acquisition was performed using a Bio-Rad Radiance2000 confocal laser scanning microscope equipped with a PlainApo 60x 1.4
NA oil-immersion objective. Images were processed and assembled in an Apple G3 computer using Adobe Photoshop 5.0. (Fig. 1A ), indicating that they are covalently cross-linked to salt-insoluble nuclear protein(s). To investigate whether they are linked to chromatin or non-chromatin nuclear structures, the Triton-and salt-extracted nuclei were digested with DNase I followed by further salt extraction. This treatment stripped ~95 % of core histones (Fig. 1A) and DNA (not shown).
Nevertheless, most of the bound CDC6 remained in the resultant nuclear pellets (Fig. 1A) . Immunofluorescence staining after the fractionation showed that the cross-linked CDC6 proteins are indeed present in nuclear dots (Fig.7) . We conclude that significant amounts of CDC6 proteins are associated with non-chromatin nuclear structures in viable HeLa cells. These fractions were also examined for MCM7 proteins, which are present in two different forms, Triton X-100-extractable and Triton-insoluble forms ( Fig. 1A ; Ref. 22 and 26) . The insoluble MCM7 was extracted with 0.5M NaCl as well as CDC6.
However, contrary to CDC6 case, only 10-20% of the insoluble MCM7 became resistant to the salt extraction even after cross-linking, and a half of this resistant form was released with chromatin by DNase I digestion (Fig. 1A) . The data is consistent with the conclusion obtained with our original fractionation method that most of the MCM complexes are associated with chromatin not affixed to non-chromatin nuclear structures (22) .
To further confirm our cross-linking method to be appropriate, we also examined whether MCM3 and MCM7 are cross-linked in vivo.
Triton X-100-extractable and the remaining nuclear fractions were (Fig. 1B) .
These data further support the utility of our in vivo cross-linking method, and also strengthen the conclusion of MCM3-MCM7 interactions in viable cells and not in the cell extracts.
CDC6 is associated with non-chromatin nuclear structure even in S phase
There remains some controversy as to behavior of CDC6 protein during S phase. Exogenously overexpressed CDC6 is translocated into cytoplasm depending on phosphorylation by CDK2 (31, 32) . Such relocation is also observed for endogenous CDC6 (23) . However, it has been also suggested that nuclear bound CDC6 still remains in S phase (23, 33) .
To revisit this problem, we examined their When formaldehyde-fixed G1 HeLa cells were stained with anti-CDC6 antibodies, nearly homogenous signals were observed in 14 nuclei ( Fig. 2A) , as we reported previously (23) . In contrast, when cells were Triton-extracted prior to the fixation, focal staining was noted in the nuclei (Fig. 2A) . The data together with the data described above (Fig.1A and 7) suggest that some CDC6 proteins may assemble into foci on non-chromatin nuclear structures. When HeLa cells in early S phase were formaldehyde-fixed and stained with the anti-CDC6, prominent cytoplasmic localization was observed ( Fig. 2A) , as we reported previously (23) . However, focal staining in nuclei was also visible and the nuclear foci were more clearly observed when cells were first Triton-extracted ( Fig. 2A) .
Data for CDC6 obtained with DSP-treated asynchronous HeLa cells ( 
Human ORC1 proteins are degraded during S phase dependent on proteasome
It has been reported that total levels of human ORC1 proteins are constant during cell cycle and that they also bind to nuclear components resistant to nuclease-directed solubilization (24, 31) .
To analyze regulation of ORC1 protein more precisely, we sought to establish HeLa cells stably expressing epitope-tagged ORC1 protein.
We constructed a vector encoding tandem HA epitope-tagged human ORC1
protein, and established HeLa cells stably expressing 2HA-ORC1. The following studies were done with HO-2, a representative HeLa line expressing 2HA-ORC1.
We first investigated the levels of the 2HA-ORC1 proteins during the cell cycle. A clear decrease was observed in the S phase cells (Fig. 3) . This is strikingly different from the previously reported finding that ORC1 protein levels are relatively constant during the cell cycle (24, 31 (Fig. 3) . No obvious difference in MCM7 or ORC2 protein levels was observed among the samples (Fig. 3) . During preparation of this paper, it was reported on the basis of work with monospecific anti-ORC1 antibodies that ORC1
is dissociated from chromatin during S phase and might be degraded in HeLa cells (36) . Together, the available data suggest that human ORC1 proteins are degraded during S phase dependent on the ubiquitin-proteasome system.
In vivo cross-linking with DSP reveals association of ORC1 with non-chromatin nuclear structure
Previously it was reported that ORC1 protein also binds to nuclease-resistant structures throughout the cell cycle (24) . We revisited this point with the HO-2 HeLa cells and our original fractionation method without DSP (22, 23) . Most 2HA-ORC1 proteins were found to bind to nuclease-resistant structures in asynchronous HO-2 cells (Fig. 4) . In vivo DSP cross-linking of asynchronous HO-2 cells and subsequent biochemical fractionation further showed 2HA-ORC1 association with non-chromatin nuclear structure (Fig. 5 ).
Immunofluorescence staining after the fractionation with anti-HA antibody further showed foci in the nuclei (Fig.7) . Taken together, these data indicate that ORC1 is associated with non-chromatin nuclear structure during G1 phase. However, it is also notable that a significant part of ORC2 proteins remain in the form associated with nuclease-resistant structures.
This fraction was extracted with 0.5M NaCl (data not shown). The distribution pattern of ORC2 proteins remained unchanged after cells entered into S phase (data not shown). We also analyzed ORC2 localization with DSP cross-linking. Unexpectedly, much of the Triton-insoluble ORC2 fraction then became resistant to DNase I-mediated solubilization (data not shown). Therefore, it could be that chromatin-associated ORC2 fraction also interacts to non-chromatin structure with a low affinity that is disrupted by 100mM NaCl contained in mCSK buffer but is cross-linked with DSP.
Alternatively, the conditions of DSP cross-linking may be inappropriate for analyses of ORC2 proteins. 
ORC1 physically interacts with ORC2 in vivo
Using HO-2 cells, we assessed physical interactions of 2HA-ORC1 with ORC2, CDC6 or MCM7. To extract these efficiently from nuclei, 0.5M NaCl is required in the extraction buffer. However, physical interactions among them are disrupted under this condition.
Therefore, nuclear extracts were prepared with buffer containing 0.25M NaCl, although results in partial solubilization. The extracts were immunoprecipitated with the rat anti-HA antibody.
ORC2 was efficiently co-precipitated with 2HA-ORC1 ( that ORC1 interacts with ORC2 on non-chromatin structures while some ORC2 proteins exist without any ORC1 association.
Immunostaining with the anti-CDC6 antibodies revealed focal nuclear staining in DSP-cross-linked and chromatin-extracted G1
phase HeLa cells (Fig.7) . In combination with the results of biochemical fractionation (Fig.1) , this suggests that multiple CDC6
proteins also assemble into foci based on non-chromatin structures.
However, only a partial colocalization was observed between 2HA-ORC1 and CDC6 foci (Fig.7) .
It has been reported that anti-MCM antibodies give homogenous nuclear staining in G1 phase, even after extracting cells with non-ionic detergents (data not shown; ref. 17, 37) . This, together with the findings that the number of MCM molecules bound to chromatin is several to ten times that of bound ORC1 or CDC6 (17, 23, 24, 31) , (Fig.1A) . To test whether the residual MCM proteins are close to the ORC1 foci, we performed double-immunostaining experiments. Most of 2HA-ORC1 foci were found to colocalize with MCM7 in DSP-treated and chromatin-extracted G1 phase HeLa cells (Fig.7) . Therefore, at least some proportion of chromatin-bound MCM complexes may be loaded near ORC1 foci. MCM7 staining not associated with 2HA-ORC1 staining was also apparent, which may represent residual chromatin-bound MCM complexes far from ORC1 foci.
Relationship between PCNA foci and ORC or CDC6 foci in early S phase cells
PCNA is one of the major components of replication foci constructed based on non-chromatin nuclear structures (8, 9) . In aphidicolin-arrested early S phase HeLa cells, PCNA foci may be built up near initiation sites of early replicons. We examined relationship between PCNA foci and ORC or CDC6 foci under these conditions by double-immunostaining and confocal microscope analyses after DSP-treatment and chromatin-extraction. Only a partial colocalization with many non-overlapping foci was observed between PCNA and ORC2 or PCNA and CDC6 foci (Fig.8 ). ORC2 and CDC6
foci not associated with PCNA foci might correspond to replicons yet unfired. However, the existence of PCNA foci not associated with ORC2 or CDC6 foci suggests that initiation of DNA replication might not necessarily occur near ORC or CDC6 foci.
It is known that MCM proteins do not colocalize at site of newly while ORC1 is difficult to detect in the complexes (40) (41) (42) (43) . It is also notable that expression of ORC2 to 5 is cell growth-independent, while ORC1 expression is driven by E2F (31, (40) (41) (42) (43) (44) . Taking these findings and our present data together, one can draw the following picture. On non-chromatin nuclear structures, ORC1 forms a complex with ORC2 (Fig. 4, 6 and 7) and probably ORC3, 4 and 5, probably functioning in DNA replication. ORC6 might also be included in the complex (43) . In addition, there is another subcomplex containing ORC2 but lacking ORC1, which binds to nuclease-sensitive chromatin (Fig.4) and may exist even in non-proliferating cells. It is not clear whether such subcomplexes also play a role in DNA replication, but more probably they may act in other function(s) (45) .
Our present data suggest that ORC1 protein is degraded via ubiquitin-proteasome system after cells entering into S phase (Fig.3) . In fission yeast, phosphorylation of Cdc18, a homologue of CDC6, by the CDK leads to its rapid degradation, which contributes to suppression of rereplication (reviewed in Ref.16 and 17 ).
However, in mammalian cells, CDC6 protein levels are unchanged after S phase ( Fig.2; Ref.23 ). Rather ORC1 degradation after S phase may contribute to prohibition of rereplication in mammalian cells.
Association of CDC6 with ORC in mammalian cells
CDC6 as well as ORC1 and ORC4 are related to RFC at the amino acid sequence level (46) . Therefore, ORC and CDC6 may cooperatively load MCM complexes. In budding yeast, CDC6 binds to origins in vivo and in vitro probably via its physical interaction with ORC (47, 48).
In the Xenopus egg extract system, although CDC6 binds to chromatin depending on ORC binding, how the latter recruits CDC6 is unclear; so far significant physical interaction has not been observed, either in the extracts or when those assembled on chromatin were analyzed (20, 21) . Therefore, their physical interaction, if any, may be unstable. In mammalian cells, it is reported that CDC6 is co-purified with ORC1 through several column chromatographic steps, and that they can physically interact in vitro (31) . However, so far we could not detect any co-immunoprecipitation between CDC6 and ORC1 or ORC2 (Fig.6) , so that the situation is similar to that in the egg extract system. Furthermore, although both ORC1 and CDC6
interact with non-chromatin nuclear structures (Figs.1 and 5 ), our double-immunostaining experiments showed only a partial colocalization (Fig.7) . The loading of MCM proteins onto chromatin occurs during late mitosis in cycling cells, when ORC proteins are abundant but the levels of CDC6 are low (30) . Therefore, only transient and weak interaction between ORC and CDC6 proteins on non-chromatin structures might be sufficient for their function to load MCM.
MCM complexes are mainly loaded onto chromatin not affixed to non-chromatin nuclear structures
In budding yeast, chromatin immunoprecipitation assays suggest that MCM proteins associate with chromatin around origins (47) . MCM is required not only for initiation but also for the elongation step (49) . One notion for MCM function is that it acts as a kind of replicative helicase, moving from an origin with elongation machinery (50, 51) . Also in Xenopus egg extract system, it is assumed that MCM complexes are loaded near ORC/CDC6 binding site.
In this case, multiple MCM complexes may be loaded on each ORC site (52) , which appears also to be the case in mammalian somatic cells (23) . Whatever, MCM may not bind to chromatin via it physical interaction with ORC/CDC6 (23, 52, 53) .
We previously suggested that most MCM complexes bind to chromatin not affixed to non-chromatin nuclear structures (23) . Our present data further indicate that while a small proportion of MCM complexes are loaded onto chromatin regions near ORC foci, most of them are more widely distributed (Fig.7) . Given that multiple MCM However, this does not appear to be the case (Fig.8) ,
suggesting that once MCM complexes are loaded onto chromatin, initiation might also occur apart from the ORC sites. Preferred initiation sites might be those that are free from nucleosomes and thus locations onto which MCM are preferentially loaded.
Alternatively, they might be sites which can easily be unwound. For the further understanding, it is very important to precisely determine distribution patterns of initiation proteins on mammalian cell replicons, for example by chromatin immunoprecipitation assays. Hydroxyurea-treated early S phase cells were analyzed as in Fig.1A . DNase I to obtain DNase I-solubilized supernatants (DNase S) and remaining DNase-resistant nuclear pellets (DNase P). These fractions were immunoblotted with anti-HA and anti-ORC2 antibodies.
As a control protein released by DNase I digestion, MCM7 was also detected in the fractions. Note that in vivo cross-linking with DSP was not used in these experiments. were also subjected to SDS-PAGE followed by Coomassie Blue staining for detection of core histones. 
